A breaking news podcast from ASCO GU in San Francisco! Prof Louise Emmett (St Vincent's, Sydney), has just read out the latest update from the ENZA-P trial (and simultaneous publication in Lancet Oncology), reporting that the combination of LuPSMA and enzalutamide improves overall survival when compared with enzalutamide alone, in men with poor prognosis mCRPC. Big news!!

Look who popped into the GU Cast studio this week for a chat about where we are going next with radioligand therapy (RLT) for prostate cancer! Professors Oliver Sartor (Mayo Clinic, Rochester) and Michael Hofman (Peter Mac, Melbourne), are two of the world's most pre-eminent experts in the world of RLT for prostate cancer.

Exclusive discussion with Arun Azad and Michael Hofman to celebrate Arun'z presentation of UpFront PSMA at ESMO24 today. Simultaneous publication in Lancet Oncology. This is a Themed Podcast supported by our Silver Partners, Novartis.

Educational and entertaining GU Cast Conference Highlights from the ProsTIC24 Preceptorship in Melbourne.

We loved having Neil Fleshner in the studio!!

Another one of our PSMA theranostics webinars in collaboration with ProsTIC, the PCF, and the International Cancer Imaging Society. Fabulous deep dive into earlier use of LuPSMA